Overview

The Genomic Expression and Neuropsychiatric Evaluation (GENE) Unit is directed by David A. Mrazek, M.D. The unit provides space for three teams of researchers interested in clinical psychiatric studies.

Researchers in the Gene Unit collaborate with other Mayo Clinic investigators to study the links between genomic variability and psychiatric illnesses such as depression, bipolar illness, and attention deficit hyperactivity disorder. Outpatient evaluations of patients and families, clinical drug trials, and multidisciplinary clinical work-ups focus on patients with depression, bipolar disorder, obsessive compulsive disorder, anxiety disorders, and schizophrenia.